<html>
<head>PUBMED IDs for RASEF</head>
<body bgcolor='#C5F0F2'><h1>RASEF</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16015647/'>Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.</a> July 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16174859/'>Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.</a> September 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16174854/'>MGMT promoter methylation and field defect in sporadic colorectal cancer.</a> September 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16174851/'>Critics question BRCA2 patent decision in Europe.</a> September 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16174847/'>DNA methylation, field effects, and colorectal cancer.</a> September 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18385040/'>Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.</a> April 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/23686708/'>RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer.</a> April 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24703243/'>Near-genomewide RNAi screening for regulators of BRAF(V600E) -induced senescence identifies RASEF, a gene epigenetically silenced in melanoma.</a> February 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26903013/'>Evaluation of polymorphisms in pbp4 gene and genetic diversity in penicillin-resistant, ampicillin-susceptible Enterococcus faecalis from hospitals in different states in Brazil.</a> December 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26903003/'>Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-ÎºB.</a> January 11  2016<br></body></html>
